First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
Clinical trial NCT01120457 · COMPLETED
Trial details
- NCT number
- NCT01120457
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2014-11-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.